BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Gamida Cell Ltd. 

Harey Yehuda 54
P.O.B. 94
Savyon    56530  Israel
Phone: 03-534-7482 Fax: 03-534-3067


SEARCH JOBS


Industry
Biotechnology






 Company News
CAS Medical Systems, Inc. (CASM) Engages CAS Medical Systems, Inc. (CASM) To Distribute FORE-SIGHT® Oximeters In France 4/16/2014 9:24:13 AM    More...
Gamida Cell Ltd. Gets Hefty Buyout Offer From Unknown Global Pharma Co., Is It Novartis AG (NVS)? 3/18/2014 7:39:06 AM    More...
Gamida Cell Ltd. Announces the Successful Transplantation of the First Patient in the Company's Phase I/II Study of NiCord® in a Single Cord Configuration 9/9/2013 10:11:57 AM    More...
Gamida Cell Ltd. Reports FDA Recommending Further Study of StemEx® 7/1/2013 7:57:10 AM    More...
Gamida Cell Ltd.'s NiCord® Demonstrates Successful Engraftment in Patients With Hematological Malignancies in Phase I/II Study 2/15/2013 9:17:49 AM    More...
Gamida Cell Ltd. Reports Success in Blood Cancer Trial 2/4/2013 7:14:23 AM    More...
Gamida Cell Ltd. Completes Enrollment for Phase I/II Study of Second Pipeline Product NiCord® for Hematological Malignancies 9/19/2012 8:47:42 AM    More...
Gamida Cell Ltd. Raises $10 Million to Progress Phase III-Stage Hematologic Cancer Cell Therapy 5/15/2012 6:56:31 AM    More...
Gamida Cell Ltd.-Teva Pharmaceutical Industries Limited (TEVA) Joint Venture Concludes Enrollment for the Phase III Study of StemEx®, a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 2/13/2012 6:13:57 AM    More...
The Gamida Cell Ltd.-Teva Pharmaceutical Industries Limited (TEVA) Joint Venture Receives Green Light From the Data Monitoring Committee to Continue the Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 7/12/2011 9:12:41 AM    More...
12345

//-->